Congressman Fred Keller co-sponsors bipartisan plan to reduce prescription drug costs

December 9, 2019
Press Release
The “Lower Costs, More Cures Act” promotes innovation, competition, transparency to make medicine affordable

Washington, D.C. — Congressman Fred Keller (R-PA) announced Monday he has co-sponsored H.R. 19, the Lower Costs, More Cures Act, a bipartisan solution aimed at lowering prescription drug prices that should be brought up for a vote immediately.


Unlike H.R. 3, Speaker Nancy Pelosi’s partisan alternative which Democrats are trying to ram through the House this week, every proposal in H.R. 19 is bipartisan. Also, unlike H.R. 3, H.R. 19 does not increase government control over the prescription drug market and limit cures, but rather increases innovation and promotes low costs options while bringing about greater transparency.


On the Lower Costs, More Cures Act, Congressman Fred Keller (R-PA) made the following statement:


“Americans pay too much for healthcare and one of the biggest contributors to rising healthcare costs is the high price of many prescription drugs. As such, I am co-sponsoring the Lower Costs, More Cures Act, bipartisan legislation that will stop skyrocketing prescription drug prices by encouraging innovation and competition, increasing transparency, and promoting more low-cost options.


“While travelling across Pennsylvania’s 12th Congressional District, I have made it a priority to meet with medical professionals and patients to discuss the topic of prescription drug prices. Their suggestions are simple: increase transparency, promote competition, and reform patent laws to allow generics to get to market faster. The Lower Costs, More Cures Act accomplishes those goals.


“The Lower Costs, More Cures Act also stands in stark contrast to Speaker Nancy Pelosi’s partisan H.R. 3, which was crafted in secret by Democrats without bipartisan input and would lead to higher prices, fewer cures, and put the country on the road to socialized medicine by increasing government control of a private healthcare industry.


“The Lower Costs, More Cures Act is a bipartisan, realistic solution to the partisan alternative House Democrats are trying to force upon Americans. If Speaker Pelosi is serious about making medicine more affordable for millions of Americans, she should immediately bring H.R. 19 up for a vote.”